2026 - Introduced
Colorado S.B. 26-006
  • Requires health insurers and Colorado Medicaid to treat FDA-approved non-opioid pain medications at least as favorably as opioids by limiting prior authorization and step therapy, ensuring non-opioid alternatives are available, and prohibiting higher cost-sharing.
  • Aims to promote non-opioid pain management by removing financial and administrative barriers.
2025 - Introduced
Georgia H.B. 326
  • Prohibits practices that disadvantage or discourage the use of non-opioid drugs relative to opioids in state employees' health insurance and benefit plans.
2025 - Introduced
Kansas H.B. 2364
  • Requires state health programs to cover non-opioid pain medications without requiring patients to try opioids first and without less favorable coverage or higher cost-sharing than opioids.
  • Prohibits formularies from disadvantaging FDA-approved non-opioid pain treatments through stricter utilization controls or tier placement.
2026 - Introduced
Missouri H.B. 1680
  • Requires commercial plans to cover non-opioid medications for acute pain without disadvantaging them compared to opioids.
2026 - Introduced
Missouri H.B. 1966
  • Requires health insurance plans to cover non-opioid medications for acute pain without denying coverage, mandating prior opioid use, or charging higher cost-sharing compared to opioids.
2026 - Introduced
Missouri H.B. 2296
  • Requires Missouri health insurance plans to cover non-opioid medications for acute pain without denying coverage, mandating prior opioid use, or charging higher cost-sharing compared to opioids.
2026 - Introduced
Missouri H.B. 2372
  • Requires insurance to cover non-opioid medications for enrollees at elevated risk of opioid misuse without requiring prior opioid use, denying coverage in favor of opioids, or imposing higher cost-sharing.
2026 - Introduced
Missouri S.B. 1024
Limits initial opioid prescriptions for acute pain in Missouri to a seven-day supply, requires practitioners to discuss risks, alternatives, and dosing options with patients, and mandates documentation if a longer supply is medically necessary.
2026 - Introduced
Missouri S.B. 902/S.B. 1340/S.B. 1449/S.B. 841
  • Requires Missouri commercial plans to cover non-opioid medications for acute pain without denying coverage in favor of opioids, mandating prior opioid use, or imposing higher cost-sharing when prescribed.
2025 - Introduced
Oklahoma H.B.1416
  • Ensures that a non-opioid drug approved by the FDA is not disadvantaged or discouraged with respect to coverage relative to an opioid for the treatment or management of pain on the state preferred drug list.
2026 - Introduced
Pennsylvania H.B. 2060
  • Requires Medicaid and commercial insurers to provide pain parity by ensuring FDA-approved non opioid drugs are not disadvantaged in coverage, cost sharing, or utilization controls compared with opioids, applying upon FDA approval.
2026 - Introduced
South Dakota H.B. 1085
  • Prohibits South Dakota insurers from denying coverage of a prescribed non-opioid medication in favor of an opioid.
  • Bars insurers from imposing stricter utilization controls or higher cost-sharing for non-opioid drugs than for clinically appropriate opioid or narcotic drugs.